https://peptideatlas.co Evidence-based peptide information, vendor reviews, safety resources, and research guides. en-us Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/what-are-peptides An accessible introduction to peptides — what they are, how they differ from proteins, and why they matter in medicine and research. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/what-are-peptides https://peptideatlas.co/resources/approved-vs-research-peptides Understand the critical differences between FDA-approved peptide drugs, compounded peptide products, and unauthorized "research" peptides sold online. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/approved-vs-research-peptides https://peptideatlas.co/resources/glp1-medications-evidence-regulation-safety A comprehensive overview of GLP-1 receptor agonists — approved medications, clinical evidence, regulatory status, and safety considerations. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/glp1-medications-evidence-regulation-safety https://peptideatlas.co/resources/fda-503a-503b-compounding An overview of the regulatory framework for pharmacy compounding under Sections 503A and 503B of the FD&C Act, including implications for peptide products. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/fda-503a-503b-compounding https://peptideatlas.co/resources/health-canada-unauthorized-peptide-warnings Summary of Health Canada warnings about unauthorized injectable peptide products sold online, including risks and regulatory context. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/health-canada-unauthorized-peptide-warnings https://peptideatlas.co/resources/wada-peptide-hormone-rules Overview of WADA prohibited peptide categories, including peptide hormones, growth factors, and related substances under the 2026 Prohibited List. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/wada-peptide-hormone-rules https://peptideatlas.co/resources/how-to-read-peptide-clinical-trial A guide to understanding clinical trial design, endpoints, statistical significance, and how to critically evaluate peptide research studies. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/how-to-read-peptide-clinical-trial https://peptideatlas.co/resources/peptide-evidence-ratings-explained How PeptideAtlas rates the strength of evidence for peptide-related claims, from approved medicines (A) to insufficient evidence (E). Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/peptide-evidence-ratings-explained https://peptideatlas.co/resources/certificate-of-analysis-guide A high-level overview of certificates of analysis (COAs) for peptide products — what they test, their limitations, and common red flags. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/certificate-of-analysis-guide https://peptideatlas.co/resources/peptide-manufacturing-cmc-basics An introduction to peptide synthesis, chemistry manufacturing and controls (CMC), and the key quality concepts behind pharmaceutical peptide production. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/peptide-manufacturing-cmc-basics https://peptideatlas.co/resources/research-use-only-labeling-compliance Why "for research use only" labels on peptides do not provide legal protection and the regulatory risks for sellers and buyers. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/research-use-only-labeling-compliance https://peptideatlas.co/resources/cgrp-migraine-approved-therapies Overview of CGRP-targeting therapies for migraine — monoclonal antibodies and gepants — as examples of successful peptide-based drug development. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/cgrp-migraine-approved-therapies https://peptideatlas.co/resources/peptide-glossary-key-terms A comprehensive glossary of terms used in peptide research, manufacturing, regulation, and clinical practice. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/peptide-glossary-key-terms https://peptideatlas.co/resources/clinical-trial-phases-explained What happens in each phase of a clinical trial, from preclinical studies through Phase IV post-marketing surveillance. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/clinical-trial-phases-explained https://peptideatlas.co/resources/peptide-market-trends-industry-landscape An overview of the global peptide therapeutics market, key growth drivers, and emerging trends for industry professionals and investors. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/peptide-market-trends-industry-landscape https://peptideatlas.co/resources/compounded-drugs-vs-fda-approved Key differences between compounded and FDA-approved drugs, including manufacturing standards, testing requirements, and patient safety implications. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/compounded-drugs-vs-fda-approved https://peptideatlas.co/resources/quality-control-concepts-peptide-products An overview of analytical testing methods, quality parameters, and quality systems used in peptide product manufacturing. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/quality-control-concepts-peptide-products https://peptideatlas.co/resources/anti-doping-basics-athletes-coaches Essential anti-doping compliance information for athletes and coaches regarding peptides, testing procedures, and therapeutic use exemptions. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/anti-doping-basics-athletes-coaches https://peptideatlas.co/resources/advertising-claims-peptide-marketing-compliance Regulatory requirements and compliance risks for marketing peptide products, including FTC, FDA, and state-level advertising rules. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/advertising-claims-peptide-marketing-compliance https://peptideatlas.co/resources/regulatory-watch-fda-health-canada-ema-wada A running summary of major regulatory developments affecting the peptide industry, including compounding rules, safety alerts, and anti-doping updates. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/regulatory-watch-fda-health-canada-ema-wada https://peptideatlas.co/resources/peptide-hormones-explained An introduction to peptide hormones — what they are, how they signal, and their roles in metabolism, growth, reproduction, and stress response. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/peptide-hormones-explained https://peptideatlas.co/resources/insulin-analogs-history-innovation The history of insulin from discovery to modern analogs — how peptide engineering transformed diabetes treatment. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/insulin-analogs-history-innovation https://peptideatlas.co/resources/peptide-contamination-risks Common contamination risks in peptide products sold outside regulated pharmaceutical channels, including microbial, chemical, and cross-contamination concerns. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/peptide-contamination-risks https://peptideatlas.co/resources/peptide-stability-storage-degradation How peptides degrade over time and the science behind proper storage conditions for lyophilized and reconstituted peptide products. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/peptide-stability-storage-degradation https://peptideatlas.co/resources/peptide-drug-conjugates-oncology How peptide-drug conjugates and peptide receptor radionuclide therapy are expanding the role of peptides in cancer treatment. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/peptide-drug-conjugates-oncology https://peptideatlas.co/resources/antimicrobial-peptides-research Overview of antimicrobial peptides (AMPs) as an emerging strategy against antibiotic-resistant bacteria, with current research status and challenges. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/antimicrobial-peptides-research https://peptideatlas.co/resources/cosmetic-peptides-dermatology A critical look at peptides used in skincare products — which have evidence, which are mostly marketing, and how to evaluate claims. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/cosmetic-peptides-dermatology https://peptideatlas.co/resources/glp1-compounding-pharmacy-landscape Overview of the 503A and 503B compounding pharmacy landscape for GLP-1 medications, including regulatory changes and market dynamics. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/glp1-compounding-pharmacy-landscape https://peptideatlas.co/resources/peptide-patent-landscape Overview of the patent and exclusivity landscape for major peptide drugs, including upcoming expirations and biosimilar/follow-on product opportunities. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/peptide-patent-landscape https://peptideatlas.co/resources/oral-peptide-delivery-technology How researchers are overcoming the challenges of oral peptide bioavailability, including absorption enhancers, enteric coatings, and nanoparticle systems. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/oral-peptide-delivery-technology https://peptideatlas.co/resources/growth-hormone-secretagogues-overview An evidence-based overview of growth hormone-releasing peptides and secretagogues — what the research shows, regulatory status, and common misconceptions. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/growth-hormone-secretagogues-overview https://peptideatlas.co/resources/fertility-peptides-reproductive-health Overview of approved peptide-based fertility treatments — GnRH agonists, antagonists, and gonadotropins used in assisted reproduction. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/fertility-peptides-reproductive-health https://peptideatlas.co/resources/eu-ema-peptide-regulatory-overview How peptide drugs are regulated in the European Union — the EMA centralized procedure, national authorizations, and pharmacovigilance requirements. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/eu-ema-peptide-regulatory-overview https://peptideatlas.co/resources/therapeutic-use-exemptions-guide How athletes can legally use prohibited peptide substances for genuine medical conditions through the TUE process. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/therapeutic-use-exemptions-guide https://peptideatlas.co/resources/peptide-cdmo-landscape Overview of the contract development and manufacturing organization (CDMO) market for peptide therapeutics, including capacity trends and key capabilities. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/peptide-cdmo-landscape https://peptideatlas.co/resources/longevity-clinic-peptide-industry Analysis of the growing longevity clinic market, how peptides fit into their offerings, and the regulatory and evidence concerns. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/longevity-clinic-peptide-industry https://peptideatlas.co/resources/peptide-supply-chain-basics An overview of the peptide pharmaceutical supply chain — raw materials, synthesis, purification, formulation, and distribution. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/peptide-supply-chain-basics https://peptideatlas.co/resources/peptides-vs-proteins-vs-small-molecules A comparison of the three major classes of therapeutic molecules — how they differ in size, manufacturing, delivery, regulation, and clinical use. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/peptides-vs-proteins-vs-small-molecules https://peptideatlas.co/resources/evaluating-peptide-health-claims A checklist for critically evaluating health claims made about peptides — red flags, evidence quality indicators, and trustworthy information sources. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/evaluating-peptide-health-claims https://peptideatlas.co/resources/fda-warning-letters-peptide-industry Analysis of common FDA enforcement actions against peptide companies — warning letter patterns, common violations, and compliance lessons. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/fda-warning-letters-peptide-industry https://peptideatlas.co/resources/approved-peptide-drug-database A reference database of FDA-approved peptide-based medications organized by therapeutic area, including brand names, indications, and approval dates. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/approved-peptide-drug-database https://peptideatlas.co/resources/peptide-industry-faq Answers to the most frequently asked questions about peptides, from basic science to regulatory status and safety. Mon, 11 May 2026 00:39:51 GMT https://peptideatlas.co/resources/peptide-industry-faq